NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Darwin Bioprospecting Excellence

Darwin Bioprospecting Excellence

Private
PaternaHealthcare & Life Scienceshttps://darwinbioprospecting.com/

Last Round

VC Round

Feb 6, 2025

Total Funding Raised

$836,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Darwin Bioprospecting Excellence is a biotechnology company that provides a bioprospecting platform for microbial research for the medical, food, and agriculture sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Alternative Fuels

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

bioprospectingmicroorganism discoverymicrobial biotechnologybiotech R&D servicesbiotech CROculturomicsmicrobe discovery platformstrain isolationmicrobiome analysisfermentation optimizationstrain improvementprobiotics developmentagricultural biosolutionsag-biomicrobial strain librarybioremediation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Darwin Bioprospecting Excellence Comps

Public and private peers based on sector, stage, and business model.

Darwin Bioprospecting Excellence comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Darwin Bioprospecting Excellence Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 6, 2025
GrantMar 7, 2024
GrantOct 5, 2023

Key People

Founding team and executive leadership

Cristina Vilanova

Chief Executive Officer, Chief Scientific Officer

Executive Team

Manuel Porcar

Chief Executive Officer

Executive Team

Darwin Bioprospecting Excellence Investors

Notable investors and investment history

Darwin Bioprospecting Excellence investors
InvestorRounds
ICEX Spain Export and InvestmentGrant
European Regional Development FundGrant
Biozell VenturesVC Round
Repsol Corporate VenturingVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 137% MoM, reaching 2.9K.

  • Nov 8, 2025

    Monthly visitors increased 365% MoM, reaching 3.3K.

Darwin Bioprospecting Excellence Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Darwin Bioprospecting Excellence Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Darwin Bioprospecting Excellence's valuation, stock price, and market status.

Firmographic Details

HeadquartersPaterna
Employee Range20
Year Founded2016
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.